federal_register: 2026-04981
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04981 | Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels | Rule | HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025. | 2026-03-13 | 2026 | 3 | https://www.federalregister.gov/documents/2026/03/13/2026-04981/mandatory-guidelines-for-federal-workplace-drug-testing-programs-authorized-testing-panels | https://www.govinfo.gov/content/pkg/FR-2026-03-13/pdf/2026-04981.pdf | Health and Human Services Department | 221 | HHS herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in federal workplace drug testing programs. The Department has made no revisions to the current drug testing panels for both urine and oral fluid and... |